Burixafor hydrobromide

Products

Inquiry

Cat. No.: IBDI-434492

Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent antagonist of CXCR4 and a well anti-angiogenic drug that is of potential value in treating choroid neovascularization. Burixafor hydrobromide (TG-0054 hydrobromide) mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction.

Size (Solution): 10 mM * 1 mL in Water

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target	CXCR
Molecular Weight	769.01
Appearance	Solid
Synonyms	TG-0054 hydrobromide
SMILES	NC1=CC(N2CCN(CCP(O)(O)=O)CC2)=NC(NC[[email protected]]3CC[[email protected]](CNCCCNC4CCCCC4)CC3)=N1.[H]Br.[5/2]
Purity	≥98.0%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.